oxazolidin-2-one has been researched along with Pneumococcal Infections in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (15.79) | 18.2507 |
2000's | 12 (63.16) | 29.6817 |
2010's | 4 (21.05) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbanat, D; Bush, K; Fernandez, J; Goldschmidt, R; Hilliard, JJ; Macielag, MJ; Melton, J | 1 |
Beach, HD; Valeron, N; Yves-Rene Linares, M | 1 |
Aydin, Y; Colak, I; Dalgic, N; Müslüman, M; Sancar, M; Yilmaz, A | 1 |
Huang, DB; Ijzerman, MM; Tack, KJ | 1 |
Andes, DR; Craig, WA; Lee, DG; Murakami, Y | 1 |
Baum, SE; Crawford, SA; Jorgensen, JH; McElmeel, ML; Whitney, CG | 1 |
Andes, D; Craig, WA; Peng, J; van Ogtrop, ML | 1 |
Abb, J | 1 |
Fişenk, I; Günalp, A; Hasçelik, G; Köseoğlu, O; Sener, B | 1 |
Biermacher, JJ; Humphrey, WR; Jensen, JL; Kuo, MS; Richards, IM; Schaadt, RD; Shattuck, MH; Smith, DP; Zielinski, RJ; Zurenko, GE | 1 |
Cha, R; Rybak, MJ | 1 |
Elkharrat, D; Farrell, DJ; Marchese, A; Schito, GC | 1 |
Bakker, S; Buckridge, S; Farrell, DJ; Felmingham, D; Morrissey, I | 1 |
Cederberg, C; Doucette, A; Gravestock, MB; Grosser, L; Hales, NJ; Hauck, SI; Poon, G | 1 |
Mikamo, H; Tanaka, K; Watanabe, K | 1 |
Batts, DH; Daley-Yates, PT; Pawsey, SD; Schaadt, RD; Stalker, DJ; Zurenko, GE | 1 |
Patel, R; Piper, KE; Rouse, MS; Steckelberg, JM | 1 |
Barbadora, K; Green, M; Kearney, JA; Mason, EO; Wald, ER | 1 |
Albut, R; Figueira, M; Pelton, SI; Stalker, D | 1 |
1 review(s) available for oxazolidin-2-one and Pneumococcal Infections
Article | Year |
---|---|
Combined retrospective analysis of seven phase II and III trials of the efficacy of linezolid in the treatment of pneumonia caused by multidrug-resistant Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Oxazolidinones; Pneumococcal Infections; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2010 |
1 trial(s) available for oxazolidin-2-one and Pneumococcal Infections
Article | Year |
---|---|
Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae | 1997 |
17 other study(ies) available for oxazolidin-2-one and Pneumococcal Infections
Article | Year |
---|---|
In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2009 |
Twenty-month-old patient with distal humerus fracture and concomitant septic arthritis.
Topics: Acetamides; Anti-Bacterial Agents; Arthritis, Infectious; Catheterization, Central Venous; Debridement; Drug Resistance, Multiple, Bacterial; Emergencies; Fracture Fixation, Internal; Fractures, Closed; Humans; Humeral Fractures; Infant; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Pneumococcal Infections; Pneumococcal Vaccines; Reoperation; Streptococcus pneumoniae; Suppuration; Therapeutic Irrigation | 2010 |
Linezolid treatment of shunt-related cerebrospinal fluid infections in children.
Topics: Acetamides; Anti-Infective Agents; Cerebral Ventricles; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Child, Preschool; Device Removal; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Linezolid; Male; Oxazolidinones; Pneumococcal Infections; Prosthesis-Related Infections; Retrospective Studies; Vancomycin Resistance; Ventriculoperitoneal Shunt | 2010 |
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Daptomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Subcutaneous; Linezolid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Vancomycin | 2013 |
Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Linezolid; Microbial Sensitivity Tests; North America; Oxazolidinones; Pneumococcal Infections; Streptococcus pneumoniae | 2002 |
In vivo pharmacodynamics of a new oxazolidinone (linezolid).
Topics: Acetamides; Animals; Anti-Bacterial Agents; Area Under Curve; Drug Resistance, Bacterial; Female; Linezolid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazolidinones; Pneumococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2002 |
Comparative activity of linezolid, quinupristin-dalfopristin and newer quinolones against Streptococcus pneumoniae.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Erythromycin; Humans; In Vitro Techniques; Linezolid; Oxazolidinones; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Virginiamycin | 2003 |
[Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Humans; Lincosamides; Macrolides; Oxazolidinones; Pneumococcal Infections; Streptococcus pneumoniae; Streptogramins | 2002 |
Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis media.
Topics: Acetamides; Acute Disease; Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Disease Models, Animal; Female; Gerbillinae; Linezolid; Microbial Sensitivity Tests; Otitis Media; Oxazolidinones; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Drug Tolerance; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pneumococcal Infections; Rifampin; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance | 2003 |
Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Ketolides; Linezolid; Macrolides; Oxazolidinones; Pneumococcal Infections; Population Surveillance; Streptococcus pneumoniae; Vancomycin | 2004 |
In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations.
Topics: Acetamides; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Humans; Ketolides; Linezolid; Macrolides; Mutation; Oxazolidinones; Pneumococcal Infections; Ribosomes; RNA, Ribosomal, 23S; Streptococcus pneumoniae; Virginiamycin | 2004 |
New carbon-linked azole oxazolidinones with improved potency and pharmacokinetics.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Colony Count, Microbial; Female; Gram-Positive Bacteria; Half-Life; Humans; Liver; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Monoamine Oxidase Inhibitors; Oxazolidinones; Pneumococcal Infections; Rats; Streptococcus pneumoniae; Structure-Activity Relationship | 2007 |
[Evaluation of efficacy of oral quinolone against Streptococcus pneumoniae AND Haemophilus influenzae with the use of Monte Carlo simulation].
Topics: Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Monte Carlo Method; Naphthyridines; Nitrofurans; Oxazolidinones; Pneumococcal Infections; Streptococcus pneumoniae | 2006 |
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillin Resistance; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin | 1999 |
In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae.
Topics: Acetamides; Acute Disease; Anti-Bacterial Agents; Child; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Linezolid; Microbial Sensitivity Tests; Otitis Media; Oxazoles; Oxazolidinones; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 1999 |
Efficacy of linezolid in experimental otitis media.
Topics: Acetamides; Amoxicillin; Animals; Anti-Bacterial Agents; Chinchilla; Disease Models, Animal; Drug Resistance, Microbial; Drug Resistance, Multiple; Haemophilus Infections; Haemophilus influenzae; Humans; Linezolid; Otitis Media; Oxazoles; Oxazolidinones; Pneumococcal Infections; Streptococcus pneumoniae | 2000 |